{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:47:30Z","timestamp":1761540450392},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2003,6,1]],"date-time":"2003-06-01T00:00:00Z","timestamp":1054425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2003,6,1]],"date-time":"2003-06-01T00:00:00Z","timestamp":1054425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2003,6,1]]},"DOI":"10.1038\/sj.bmt.1704087","type":"journal-article","created":{"date-parts":[[2003,6,10]],"date-time":"2003-06-10T10:43:24Z","timestamp":1055241804000},"page":"1143-1149","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Low molecular weight heparin for the prevention of hepatic veno-occlusive disease (VOD) after hematopoietic stem cell transplantation: a prospective phase II study"],"prefix":"10.1038","volume":"31","author":[{"given":"D L","family":"Forrest","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V G","family":"Dorcas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S H","family":"Couban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Pierce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,6,10]]},"reference":[{"key":"BF1704087_CR1","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1200\/JCO.1988.6.10.1562","volume":"6","author":"SI Bearman","year":"1988","unstructured":"Bearman SI, Appelbaum FR, Buckner CD et al. Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol 1988; 6: 1562.","journal-title":"J Clin Oncol"},{"key":"BF1704087_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/hep.1840040121","volume":"4","author":"GB McDonald","year":"1984","unstructured":"McDonald GB, Sharma P, Matthews DE et al. Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology 1984; 4: 16.","journal-title":"Hepatology"},{"key":"BF1704087_CR3","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1097\/00007890-198712000-00011","volume":"44","author":"RJ Jones","year":"1987","unstructured":"Jones RJ, Lee KSK, Beschorner WE et al. Venocclusive disease of the liver following bone marrow transplantation. Transplant 1987; 44: 778.","journal-title":"Transplant"},{"key":"BF1704087_CR4","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1097\/00007890-198706000-00020","volume":"43","author":"FL Dulley","year":"1987","unstructured":"Dulley FL, Kanfer EJ, Appelbaum FR et al. Venocclusive disease of the liver after chemoradiotherapy and autologous bone marrow transplantation. Transplant 1987; 43: 870.","journal-title":"Transplant"},{"key":"BF1704087_CR5","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1200\/JCO.1990.8.10.1699","volume":"8","author":"LJ Ayash","year":"1990","unstructured":"Ayash LJ, Hunt M, Antman K et al. Hepatic venocclusive disease in autologous bone marrow transplantation of solid tumors and lymphomas. J Clin Oncol 1990; 8: 1699.","journal-title":"J Clin Oncol"},{"key":"BF1704087_CR6","doi-asserted-by":"publisher","first-page":"255","DOI":"10.7326\/0003-4819-118-4-199302150-00003","volume":"118","author":"GB McDonald","year":"1993","unstructured":"McDonald GB, Hinds MS, Fisher LD et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med 1993; 118: 255.","journal-title":"Ann Intern Med"},{"key":"BF1704087_CR7","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1182\/blood.V85.11.3005.bloodjournal85113005","volume":"85","author":"SI Bearman","year":"1995","unstructured":"Bearman SI . The syndrome of hepatic veno-occlusive disease after marrow transplantation. Blood 1995; 85: 3005.","journal-title":"Blood"},{"key":"BF1704087_CR8","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1046\/j.1365-2141.1999.01680.x","volume":"107","author":"P Richardson","year":"1999","unstructured":"Richardson P, Guinan E . The pathology, diagnosis, and treatment of hepatic veno-occlusive disease: current status and novel approaches. Br J Haematol 1999; 107: 485.","journal-title":"Br J Haematol"},{"key":"BF1704087_CR9","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1002\/hep.1840190515","volume":"19","author":"HM Shulman","year":"1994","unstructured":"Shulman HM, Fisher LB, Schoch HG et al. Venoocclusive disease of the liver after marrow transplantation: histological correlates of clinical signs and symptoms. Hepatology 1994; 19: 1171.","journal-title":"Hepatology"},{"key":"BF1704087_CR10","first-page":"197","volume":"10","author":"HM Shulman","year":"1992","unstructured":"Shulman HM, Hinterberger W . Hepatic veno-occlusive disease\u2014liver toxicity syndrome after bone marrow transplantation. Bone Marrow Transplant 1992; 10: 197.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704087_CR11","first-page":"75","volume":"17","author":"C Rozman","year":"1996","unstructured":"Rozman C, Carreras E, Qian C et al. Risk factors for hepatic veno-occlusive disease following HLA-identical sibling bone marrow transplants for leukemia. Bone Marrow Transplant 1996; 17: 75.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704087_CR12","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/sj.bmt.1700895","volume":"20","author":"M Kami","year":"1997","unstructured":"Kami M, Mori S, Tanikawa S et al. Risk factors for hepatic veno-occlusive disease after bone marrow transplantation: retrospective analysis of 137 cases at a single institution. Bone Marrow Transplant 1997; 20: 397.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704087_CR13","first-page":"3599","volume":"92","author":"E Carreras","year":"1998","unstructured":"Carreras E, Bertz H, Arcese W et al. On behalf of the European Group for Blood and Marrow Transplantation Chronic Leukemia Working Party. Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European group for blood and marrow transplantation. Blood 1998; 92: 3599.","journal-title":"Blood"},{"key":"BF1704087_CR14","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/j.1365-2141.1990.tb02583.x","volume":"74","author":"E Gluckman","year":"1990","unstructured":"Gluckman E, Jolivet I, Scrobohaci ML et al. Use of prostaglandin E1 for prevention of liver veno-occlusive disease in leukaemic patients treated by allogeneic bone marrow transplantation. Br J Haematol 1990; 74: 277.","journal-title":"Br J Haematol"},{"key":"BF1704087_CR15","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1182\/blood.V82.3.732.732","volume":"82","author":"M Attal","year":"1993","unstructured":"Attal M, Huguet F, Rubie H et al. Prevention of regimen-related toxicities after bone marrow transplantation by pentoxifylline: a prospective, randomized trial. Blood 1993; 82: 732.","journal-title":"Blood"},{"key":"BF1704087_CR16","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1182\/blood.V82.7.2025.2025","volume":"892","author":"RA Clift","year":"1993","unstructured":"Clift RA, Bianco JA, Appelbaum FR et al. A randomized controlled trial of pentoxifylline for the prevention of regimen-related toxicities in patients undergoing allogeneic marrow transplantation. Blood 1993; 892: 2025.","journal-title":"Blood"},{"key":"BF1704087_CR17","doi-asserted-by":"publisher","first-page":"975","DOI":"10.7326\/0003-4819-128-12_Part_1-199806150-00002","volume":"128","author":"JH Essell","year":"1998","unstructured":"Essell JH, Schroeder MT, Harman GS et al. Ursodiol prophylaxis against hepatic complications of allogeneic bone marrow transplantation: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 1998; 128: 975.","journal-title":"Ann Intern Med"},{"key":"BF1704087_CR18","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1182\/blood-2001-12-0159","volume":"100","author":"T Ruutu","year":"2002","unstructured":"Ruutu T, Eriksson B, Remes K et al. Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation. Blood 2002; 100: 1977.","journal-title":"Blood"},{"key":"BF1704087_CR19","first-page":"266","volume":"3","author":"BY Rio","year":"1988","unstructured":"Rio BY, Lamy T, Zittoun R . Preventive role of heparin for liver veno-occlusive disease (VOD). Bone Marrow Transplant 1988; 3: 266.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704087_CR20","first-page":"407","volume":"5","author":"SI Bearman","year":"1990","unstructured":"Bearman SI, Hinds MS, Wolford JL et al. A pilot study of continuous infusion heparin for the prevention of hepatic veno-occlusive disease after bone marrow transplantation. Bone Marrow Transplant 1990; 5: 407.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704087_CR21","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/j.1600-0609.1991.tb01859.x","volume":"47","author":"L Marsa-Vila","year":"1991","unstructured":"Marsa-Vila L, Gorin NC, Laporte JP et al. Prophylactic heparin does not prevent liver veno-occlusive disease following autologous bone marrow transplantation. Eur J Haematol 1991; 47: 346.","journal-title":"Eur J Haematol"},{"key":"BF1704087_CR22","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1182\/blood.V79.11.2834.bloodjournal79112834","volume":"79","author":"M Attal","year":"1992","unstructured":"Attal M, Huguet F, Rubie H et al. Prevention of hepatic veno-occlusive disease after bone marrow transplantation by continuous infusion of low-dose heparin: a prospective randomized trial. Blood 1992; 79: 2834.","journal-title":"Blood"},{"key":"BF1704087_CR23","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1182\/blood.V80.8.2149.2149","volume":"80","author":"JY Cahn","year":"1992","unstructured":"Cahn JY, Flesch M, Brion A et al. Prevention of veno-occlusive disease of the liver after bone marrow transplantation: heparin or no heparin? Blood 1992; 80: 2149.","journal-title":"Blood"},{"key":"BF1704087_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V79.1.1.1","volume":"79","author":"J Hirsh","year":"1992","unstructured":"Hirsh J, Levine MN . Low molecular weight heparin. Blood 1992; 79: 1.","journal-title":"Blood"},{"key":"BF1704087_CR25","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1002\/bjs.1800750920","volume":"75","author":"D Bergqvist","year":"1988","unstructured":"Bergqvist D, Matzsch T, Burmark US et al. Low molecular weight heparin given the evening before surgery compared with conventional low dose heparin in prevention of thrombosis. Br J Surg 1988; 75: 888.","journal-title":"Br J Surg"},{"key":"BF1704087_CR26","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1055\/s-0038-1642757","volume":"59","author":"JP Caen","year":"1988","unstructured":"Caen JP . A randomized double-blind study between a low molecular weight heparin Kabi 2165 and standard heparin in the prevention of deep vein thrombosis in general surgery. Thromb Haemost 1988; 59: 216.","journal-title":"Thromb Haemost"},{"key":"BF1704087_CR27","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1056\/NEJM199603143341102","volume":"334","author":"MMW Koopman","year":"1996","unstructured":"Koopman MMW, Prandoni P, Piovella F et al. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. N Engl J Med 1996; 334: 682.","journal-title":"N Engl J Med"},{"key":"BF1704087_CR28","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P . Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457.","journal-title":"J Am Stat Assoc"},{"key":"BF1704087_CR29","doi-asserted-by":"publisher","first-page":"4337","DOI":"10.1182\/blood-2002-04-1216","volume":"100","author":"PG Richardson","year":"2002","unstructured":"Richardson PG, Murakami C, Jin Z et al. Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcome. Blood 2002; 100: 4337.","journal-title":"Blood"},{"key":"BF1704087_CR30","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1056\/NEJM199505183322003","volume":"332","author":"TE Warkentin","year":"1995","unstructured":"Warkentin TE, Levine MN, Hirsh J et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 1995; 332: 1330.","journal-title":"N Engl J Med"},{"key":"BF1704087_CR31","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1097\/00007890-199604150-00014","volume":"61","author":"R Or","year":"1996","unstructured":"Or R, Nagler A, Shpilberg O et al. Low molecular weight heparin for the prevention of veno-occlusive disease of the liver in bone marrow transplantation patients. Transplant 1996; 61: 1067.","journal-title":"Transplant"},{"key":"BF1704087_CR32","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/sj.bmt.1702717","volume":"27","author":"S Nevo","year":"2001","unstructured":"Nevo S, Enger C, Hartley E et al. Acute bleeding and thrombocytopenia after bone marrow transplantation. Bone Marrow Transplant 2001; 27: 65.","journal-title":"Bone Marrow Transplant"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1704087.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1704087","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1704087.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T23:46:53Z","timestamp":1648079213000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1704087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,6,1]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2003,6,1]]}},"alternative-id":["BF1704087"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1704087","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,6,1]]},"assertion":[{"value":"27 September 2002","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2003","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2003","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}